News
Upcoming Events
GSC Collaborator Forum 2025
-
BC Cancer Research Centre & Blusson Spinal Cord Centre
Transcriptional and epigenetic response of different cell types to F. nucleatum
Research on the role Fusobacterium nucleatum plays in cancer shows that the transcriptome and epigenome of different host cell types are affected by the pathogen in different ways.
How B.C. scientists are addressing the COVID-19 testing challenge
As the COVID-19 pandemic continues, public health authorities around the world are facing a significant challenge: ensuring a large enough supply of reagents to scale-up diagnostic testing. Researchers at Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC), the University of British Columbia (UBC) and the BC Centre for Disease Control (BCCDC) are working to develop new non-proprietary reagents to support current and future testing in British Columbia.
Finding DNA evidence of bacterial contamination in cancer therapies
Researchers have developed a rapid and highly sensitive method for ensuring cell-based cancer therapies are contaminant-free.
GSC scientists develop a new method for finding cancer-killing cells
Harnessing the power of our own immune systems can help fight off cancer. Researchers at the BC Cancer Genome Sciences Centre have developed a method to tell immune cells exactly what to look for
Canada’s Michael Smith Genome Sciences Centre respectfully acknowledges that we operate on the traditional, ancestral and unceded territories of the xʷməθkwəy̓əm (Musqueam), Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and Skwxwú7mesh (Squamish) nations who have cared and nurtured this land for all time. We give thanks, as uninvited guests, to be able to live and work on these lands.
